Anti-CYP4A11

Anti-CYP4A11
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
ATA-HPA057764.100 100 µl

7 - 10 Werktage*

463,00 €
 
Rabbit Polyclonal CYP4A11 Antibody against Human cytochrome P450 family 4 subfamily A member 11.... mehr
Produktinformationen "Anti-CYP4A11"
Rabbit Polyclonal CYP4A11 Antibody against Human cytochrome P450 family 4 subfamily A member 11. Validated for Western Blot. Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. Interspecies information: Highest antigen sequence indentity to the following orthologs: ENSMUSG00000078597: 86%, ENSRNOG00000008842: 84%. Protein function: A cytochrome P450 monooxygenase involved in the metabolism of fatty acids and their oxygenated derivatives (oxylipins) (PubMed:7679927, PubMed:1739747, PubMed:8914854, PubMed:10553002, PubMed:10660572, PubMed:15611369). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR, NADPH-ferrihemoprotein reductase) (PubMed:7679927, PubMed:1739747, PubMed:8914854, PubMed:10553002, PubMed:10660572, PubMed:15611369). Catalyzes predominantly the oxidation of the terminal carbon (omega-oxidation) of saturated and unsaturated fatty acids, the catalytic efficiency decreasing in the following order: dodecanoic > tetradecanoic > (9Z)-octadecenoic > (9Z,12Z)-octadecadienoic > hexadecanoic acid (PubMed:10553002, PubMed:10660572). Acts as a major omega-hydroxylase for dodecanoic (lauric) acid in liver (PubMed:7679927, PubMed:1739747, PubMed:8914854, PubMed:15611369). Participates in omega-hydroxylation of (5Z,8Z,11Z,14Z)-eicosatetraenoic acid (arachidonate) to 20- hydroxyeicosatetraenoic acid (20-HETE), a signaling molecule acting both as vasoconstrictive and natriuretic with overall effect on arterial blood pressure (PubMed:10620324, PubMed:10660572, PubMed:15611369). Can also catalyze the oxidation of the penultimate carbon (omega-1 oxidation) of fatty acids with lower efficiency (PubMed:7679927). May contribute to the degradation of saturated very long-chain fatty acids (VLCFAs) such as docosanoic acid, by catalyzing successive omega-oxidations to the corresponding dicarboxylic acid, thereby initiating chain shortening (PubMed:18182499). Omega- hydroxylates (9R,10S)-epoxy-octadecanoate stereoisomer (PubMed:15145985). Plays a minor role in omega-oxidation of long-chain 3-hydroxy fatty acids (PubMed:18065749). Has little activity toward prostaglandins A1 and E1 (PubMed:7679927). [The UniProt Consortium]
Schlagworte: Anti-CYP4A2, Anti-CYP4AII, Anti-CYPIVA11, Anti-20-HETE synthase, Anti-Cytochrome P450 4A11, Anti-Cytochrome P450HL-omega, Anti-Cytochrome P-450HK-omega, Anti-Fatty acid omega-hydroxylase, Anti-Lauric acid omega-hydroxylase
Hersteller: Atlas Antibodies
Hersteller-Nr: HPA057764

Eigenschaften

Anwendung: WB
Antikörper-Typ: Polyclonal
Konjugat: No
Wirt: Rabbit
Spezies-Reaktivität: human
Immunogen: WLWGGKVRVQ LYDPDYMKVI LGRSDPKSHG
Format: Affinity Purified

Handhabung & Sicherheit

Lagerung: -20°C (+4 °C for short term storage)
Versand: +20°C (International: +20°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-CYP4A11"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen